BCL2 and neoplasm: For TN tumors, larger tumor size [HR = 2.5 (1.2–5.3), P = 0.02], nodal involvement [HR = 3.5 (1.6–7.6), P = 0.002], Trio [HR = 2.4 (1.1–5.1), P = 0.03], and BCL2 [HR = 3.3 (1.3–8.4), P = 0.01] phenotypes were associated with poorer DMFS.